Signaling pathways influencing tumor microenvironment and their exploitation for targeted drug delivery

Abstract In the recent years, the “tumor microenvironment” has been receiving growing attention due to its involvement in neoplastic transformation, tumor growth, invasion, and protection of tumor cells from host immune response. All these events are facilitated by chemical signals produced by the tumor as well as the surrounding stromal cells. This review is divided into two main parts in which the first part discusses the receptor tyrosine kinase (RTK)-mediated growth factor signaling, steroid hormone (SH) signaling, ancient signaling pathways, and other molecules that are involved in tumorigenesis and how they interact with each other to create a complex tumor microenvironment. In the second part, we bring together the recent nanocarrier-mediated drug delivery approaches to target the signaling pathways/molecules present in the tumor microenvironment.

[1]  W. Rutter,et al.  Expression and characterization of a functional human insulin-like growth factor I receptor. , 1988, The Journal of biological chemistry.

[2]  Amit Jain,et al.  Development of surface-functionalised nanoparticles for FGF2 receptor-based solid tumour targeting , 2012, Journal of microencapsulation.

[3]  R. Roskoski,et al.  Vascular endothelial growth factor (VEGF) signaling in tumor progression. , 2007, Critical reviews in oncology/hematology.

[4]  L. Strizzi,et al.  Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis , 2009, Oncogene.

[5]  Andrius Kazlauskas,et al.  PDGF signaling in cells and mice. , 2004, Cytokine & growth factor reviews.

[6]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[7]  Erik C. Dreaden,et al.  Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. , 2009, Bioconjugate chemistry.

[8]  M. Kazanietz,et al.  Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways , 2010, Cell cycle.

[9]  J. Kuemmerle IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[10]  Patrick Maisonneuve,et al.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.

[11]  B. Groner,et al.  The Biological Functions of the Versatile Transcription Factors STAT3 and STAT5 and New Strategies for their Targeted Inhibition , 2006, Journal of Mammary Gland Biology and Neoplasia.

[12]  U. Rüther,et al.  The Shh-independent activator function of the full-length Gli3 protein and its role in vertebrate limb digit patterning. , 2007, Developmental biology.

[13]  F. Puglisi,et al.  Overcoming Treatment Resistance in HER2-Positive Breast Cancer , 2012, Drugs.

[14]  T. Dønnem,et al.  Co-expression of PDGF-B and VEGFR-3 strongly correlates with lymph node metastasis and poor survival in non-small-cell lung cancer. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  M. Frohman,et al.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. , 2009, Future oncology.

[16]  A. Tedesco,et al.  Characterization of biodegradable poly(D,L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. , 2007, Photomedicine and laser surgery.

[17]  R. Gabathuler,et al.  Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.

[18]  H. Antoniades,et al.  Expression of platelet‐derived growth factor (PDGF)‐A, PDGF‐B and the PDGF‐alpha receptor, but not the PDGF‐beta receptor, in human malignant melanoma in vivo , 1996, The British journal of dermatology.

[19]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[20]  T. Park,et al.  Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. , 2008, Bioconjugate chemistry.

[21]  P. Rida,et al.  A Notch feeling of somite segmentation and beyond. , 2004, Developmental biology.

[22]  Cheryl S Watson,et al.  Membrane estrogen receptor-α levels in MCF-7 breast cancer cells predict cAMP and proliferation responses , 2004, Breast Cancer Research.

[23]  R. Habas,et al.  SnapShot: Noncanonical Wnt Signaling Pathways , 2007, Cell.

[24]  M. Emi,et al.  Amplification, up‐regulation and over‐expression of DVL‐1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers , 2003, Cancer science.

[25]  A. Harris,et al.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Liz Y. Han,et al.  Functional significance of VEGFR‐2 on ovarian cancer cells , 2009, International journal of cancer.

[27]  A. Goate,et al.  Aph-2/Nicastrin An Essential Component of γ-Secretase and Regulator of Notch Signaling and Presenilin Localization , 2002, Neuron.

[28]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[29]  A. Belfiore,et al.  Insulin receptor and cancer. , 2011, Endocrine-related cancer.

[30]  Yosef Yarden,et al.  Signal transduction and oncogenesis by ErbB/HER receptors. , 2004, International journal of radiation oncology, biology, physics.

[31]  Charles M Perou,et al.  A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. , 2009, Cancer research.

[32]  J. Budczies,et al.  Heterogeneous expression of Wnt/β‐catenin target genes within colorectal cancer , 2007, International journal of cancer.

[33]  Ji Luo,et al.  The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.

[34]  A. Atfi,et al.  Insulin-Mediated Cell Proliferation and Survival Involve Inhibition of c-Jun N-terminal Kinases through a Phosphatidylinositol 3-Kinase- and Mitogen-Activated Protein Kinase Phosphatase-1-Dependent Pathway. , 2000, Endocrinology.

[35]  T. Noda,et al.  Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.

[36]  S. Burma,et al.  Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. , 2010, Neoplasia.

[37]  G. Hortobagyi,et al.  Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. , 2004, Cancer cell.

[38]  W. Engström,et al.  Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review , 2012, Gerontology.

[39]  W. Cavenee,et al.  Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. , 2003, The American journal of pathology.

[40]  H. Werner,et al.  The insulin-like growth factor-I receptor as an oncogene , 2009, Archives of physiology and biochemistry.

[41]  Luzhe Sun,et al.  Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. , 2010, Cancer research.

[42]  P. Pisani Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies. , 2008, Archives of physiology and biochemistry.

[43]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  A. Chott,et al.  Platelet-Derived Growth Factor-AA and -α Receptor Expression Suggests an Autocrine and/or Paracrine Loop in Osteosarcoma , 2000, Modern Pathology.

[45]  L. Williams,et al.  Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  I. Palmeirim,et al.  Joint interpretation of AER/FGF and ZPA/SHH over time and space underlies hairy2 expression in the chick limb , 2012, Biology Open.

[47]  J. Griffin,et al.  Modulation of Notch signaling by mastermind-like (MAML) transcriptional co-activators and their involvement in tumorigenesis. , 2004, Seminars in cancer biology.

[48]  D. Min,et al.  Positive Feedback Regulation between Phospholipase D and Wnt Signaling Promotes Wnt-Driven Anchorage-Independent Growth of Colorectal Cancer Cells , 2010, PloS one.

[49]  Scott R. Presnell,et al.  A dual-targeting PDGFRβ/VEGF-A molecule assembled from stable antibody fragments demonstrates anti-angiogenic activity in vitro and in vivo , 2010, mAbs.

[50]  G. Viglietto,et al.  The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib , 2006, Journal of cellular physiology.

[51]  Barbara Stecca,et al.  Context-dependent regulation of the GLI code in cancer by HEDGEHOG and non-HEDGEHOG signals. , 2010, Journal of molecular cell biology.

[52]  L. Miele,et al.  Cancer stem cells – an old idea that’s new again: implications for the diagnosis and treatment of breast cancer , 2007, Expert opinion on biological therapy.

[53]  Laura Sciacca,et al.  Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. , 2009, Endocrine reviews.

[54]  Zhiwei Wang,et al.  Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.

[55]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[56]  Jinho Park,et al.  Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy , 2012, Theranostics.

[57]  M. V. Lozano,et al.  Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[58]  Thomas E Rohan,et al.  Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. , 2009, Journal of the National Cancer Institute.

[59]  Deepa Subramanyam,et al.  Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis , 2009, Molecular Cancer.

[60]  N. Hynes,et al.  Differential Roles of Fibroblast Growth Factor Receptors (FGFR) 1, 2 and 3 in the Regulation of S115 Breast Cancer Cell Growth , 2012, PloS one.

[61]  Ashok R Venkitaraman,et al.  Cancer Susceptibility and the Functions of BRCA1 and BRCA2 , 2002, Cell.

[62]  J. Kreuter Transport of Drugs Across the Blood-Brain Barrier by Nanoparticles , 2002 .

[63]  M. Sigvardsson,et al.  The Notch-2 Gene Is Regulated by Wnt Signaling in Cultured Colorectal Cancer Cells , 2011, PloS one.

[64]  M. Ittmann,et al.  Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[65]  F. Oswald,et al.  The Notch signaling pathway: Transcriptional regulation at Notch target genes , 2009, Cellular and Molecular Life Sciences.

[66]  A. Pandiella,et al.  HER3 overexpression and survival in solid tumors: a meta-analysis. , 2013, Journal of the National Cancer Institute.

[67]  R. Kageyama,et al.  HES-1 preserves purified hematopoietic stem cells ex vivo and accumulates side population cells in vivo. , 2003, Blood.

[68]  P. Sánchez,et al.  HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.

[69]  A. Maitra,et al.  Polymeric Nanoparticle-Encapsulated Hedgehog Pathway Inhibitor HPI-1 (NanoHHI) Inhibits Systemic Metastases in an Orthotopic Model of Human Hepatocellular Carcinoma , 2011, Clinical Cancer Research.

[70]  R. Clarke,et al.  Mammary Stem Cells and Breast Cancer—Role of Notch Signalling , 2007, Stem Cell Reviews.

[71]  G. Christofori,et al.  Placental growth factor-1 attenuates vascular endothelial growth factor-A-dependent tumor angiogenesis during beta cell carcinogenesis. , 2007, Cancer research.

[72]  B. Hemmings,et al.  Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.

[73]  Ryoichiro Kageyama,et al.  The role of Hes genes in intestinal development, homeostasis and tumor formation , 2012, Development.

[74]  A. Karsan,et al.  Recent insights into the role of Notch signaling in tumorigenesis. , 2006, Blood.

[75]  D. Bar-Sagi,et al.  Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos , 2007, Nature Cell Biology.

[76]  M. Bernier,et al.  Akt-dependent antiapoptotic action of insulin is sensitive to farnesyltransferase inhibitor. , 2000, Biochemistry.

[77]  Nancy L Oleinick,et al.  EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[78]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[79]  R. Swann,et al.  Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers , 2010, Clinical Cancer Research.

[80]  J. Pell,et al.  Differential regulation of transcription initiation from insulin-like growth factor-I (IGF-I) leader exons and of tissue IGF-I expression in response to changed growth hormone and nutritional status in sheep. , 1993, Endocrinology.

[81]  Qiulian Wu,et al.  Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. , 2012, Genes & development.

[82]  Zhiwei Wang,et al.  RETRACTED ARTICLE: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways , 2011, Breast Cancer Research and Treatment.

[83]  J. Trevino,et al.  c-Src Regulates Constitutive and EGF-mediated VEGF Expression in Pancreatic Tumor Cells Through Activation of Phosphatidyl Inositol-3 Kinase and p38 MAPK , 2005, Pancreas.

[84]  D. Rose,et al.  The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. , 2012, Endocrine-related cancer.

[85]  S. Barsky,et al.  ERα suppresses slug expression directly by transcriptional repression , 2008, The Biochemical journal.

[86]  Michael J Yaszemski,et al.  Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis , 2007, Journal of nanobiotechnology.

[87]  I. Kasman,et al.  PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. , 2009, Cancer cell.

[88]  M. Mimeault,et al.  Frequent Deregulations in the Hedgehog Signaling Network and Cross-Talks with the Epidermal Growth Factor Receptor Pathway Involved in Cancer Progression and Targeted Therapies , 2010, Pharmacological Reviews.

[89]  Y. Oh,et al.  Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[90]  A. Zmijewska,et al.  Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3* , 2005, Journal of Biological Chemistry.

[91]  Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. , 2007, The American journal of pathology.

[92]  J. Bishop,et al.  Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[93]  Fang Wang,et al.  Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. , 2012, Chemistry, an Asian journal.

[94]  S. Frisch,et al.  Anoikis mechanisms. , 2001, Current opinion in cell biology.

[95]  M. Shibuya,et al.  Vascular endothelial growth factor receptor-1 signaling promotes mobilization of macrophage lineage cells from bone marrow and stimulates solid tumor growth. , 2010, Cancer research.

[96]  Randall T. Moon,et al.  Wnt and calcium signaling: β-Catenin-independent pathways , 2005 .

[97]  C. Rudin,et al.  A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists , 2011, Molecular Cancer Therapeutics.

[98]  P. Neth,et al.  The Wnt Signal Transduction Pathway in Stem Cells and Cancer Cells: Influence on Cellular Invasion , 2007, Stem Cell Reviews.

[99]  N. Caplen,et al.  Gene Therapy Progress and Prospects. Downregulating gene expression: the impact of RNA interference , 2004, Gene Therapy.

[100]  G. Tzivion,et al.  FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. , 2011, Biochimica et biophysica acta.

[101]  Mauro Ferrari,et al.  Nanogeometry: beyond drug delivery. , 2008, Nature nanotechnology.

[102]  K. Izumi,et al.  Inhibitory effect of soluble platelet‐derived growth factor receptor β on intraosseous growth of breast cancer cells in nude mice , 2011, Cancer science.

[103]  W. Berdel,et al.  Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[104]  上野 耕司 Frizzled-7 as a potential therapeutic target in colorectal cancer , 2009 .

[105]  J. Meyerhardt,et al.  Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[106]  Guang Liang,et al.  Anticancer molecules targeting fibroblast growth factor receptors. , 2012, Trends in pharmacological sciences.

[107]  D. A. Russell,et al.  Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[108]  P. Rennie,et al.  Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo , 2012, International journal of cancer.

[109]  Caicun Zhou,et al.  Integrin beta1 over‐expression associates with resistance to tyrosine kinase inhibitor gefitinib in non‐small cell lung cancer , 2010, Journal of cellular biochemistry.

[110]  J. Krise,et al.  Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review. , 2005, Frontiers in bioscience : a journal and virtual library.

[111]  Stephen B. Baylin,et al.  Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.

[112]  Doaa A. Abdel Fadeel,et al.  Zinc phthalocyanine-loaded PLGA biodegradable nanoparticles for photodynamic therapy in tumor-bearing mice , 2010, Lasers in Medical Science.

[113]  David J. Yang,et al.  Prognostic Effect of Epidermal Growth Factor Receptor and EGFRvIII in Glioblastoma Multiforme Patients , 2005, Clinical Cancer Research.

[114]  Edward J Oakeley,et al.  WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth , 2009, Breast Cancer Research.

[115]  R. Boyle,et al.  Polyacrylamide nanoparticles as a delivery system in photodynamic therapy. , 2011, Molecular pharmaceutics.

[116]  Manuel Arruebo,et al.  Antibody-conjugated nanoparticles for biomedical applications , 2009 .

[117]  D. Alessi,et al.  Role of the PDK1–PKB–GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart , 2005, FEBS letters.

[118]  Maria Kasper,et al.  Selective Modulation of Hedgehog/GLI Target Gene Expression by Epidermal Growth Factor Signaling in Human Keratinocytes , 2006, Molecular and Cellular Biology.

[119]  A. Merchant,et al.  Targeting Hedgehog — a Cancer Stem Cell Pathway , 2010, Clinical Cancer Research.

[120]  L. Chin,et al.  Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.

[121]  S. Nair,et al.  Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. , 2013, Carbohydrate polymers.

[122]  J. Balligand,et al.  Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[123]  Michael D Schaller,et al.  The interplay between Src and integrins in normal and tumor biology , 2004, Oncogene.

[124]  J. Kreuter,et al.  Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? , 2014, Advanced drug delivery reviews.

[125]  M. Moasser,et al.  The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.

[126]  B. Liu,et al.  Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[127]  M. Shupnik,et al.  Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance. , 2007, Molecular endocrinology.

[128]  Barbara Stecca,et al.  Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways , 2007, Proceedings of the National Academy of Sciences.

[129]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[130]  A. Capobianco,et al.  Induction of Cyclin D1 Transcription and CDK2 Activity by Notchic: Implication for Cell Cycle Disruption in Transformation by Notchic , 2001, Molecular and Cellular Biology.

[131]  C. Gicquel,et al.  Loss of heterozygosity at the mannose 6-phosphate/insulin-like growth factor 2 receptor locus: a frequent but late event in adrenocortical tumorigenesis. , 2001, European journal of endocrinology.

[132]  F. Marshall,et al.  The Prostate 69 : 949 ^ 955 ( 2009 ) Soluble FactorsDerived FromStromaActivated AndrogenReceptor Phosphorylation inHuman Prostate LNCaPCells : Roles of ERK / MAPKinase , 2009 .

[133]  Sarat Chandarlapaty,et al.  AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. , 2011, Cancer cell.

[134]  G. Martin The hunting of the Src , 2001, Nature Reviews Molecular Cell Biology.

[135]  Barbara Stecca,et al.  The Gli code: an information nexus regulating cell fate, stemness and cancer. , 2007, Trends in cell biology.

[136]  Allen Li,et al.  Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. , 2007, Cancer research.

[137]  Geng-yin Zhou,et al.  Interference of Frizzled 1 (FZD1) reverses multidrug resistance in breast cancer cells through the Wnt/β-catenin pathway. , 2012, Cancer letters.

[138]  I. Palmeirim,et al.  Comprehensive analysis of fibroblast growth factor receptor expression patterns during chick forelimb development. , 2010, The International journal of developmental biology.

[139]  W. Bushman Hedgehog Signaling in Development and Cancer , 2007 .

[140]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[141]  David Cunningham,et al.  Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine. , 2009, Recent patents on anti-cancer drug discovery.

[142]  M. Datta,et al.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Andhra Pradesh,et al.  NANOPARTICLES AS DRUG DELIVERY SYSTEMS , 2012 .

[144]  Jia Zhou,et al.  Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. , 2013, Biomaterials.

[145]  C. Weston,et al.  The JNK signal transduction pathway. , 2007, Current opinion in genetics & development.

[146]  A. Harris,et al.  New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. , 1998, The cancer journal from Scientific American.

[147]  B. O’Malley,et al.  Nuclear receptor coregulators in cancer biology. , 2009, Cancer research.

[148]  G. Christofori,et al.  Placental Growth Factor-1 Attenuates Vascular Endothelial Growth Factor-A–Dependent Tumor Angiogenesis during β Cell Carcinogenesis , 2007 .

[149]  M. Nguyen,et al.  Estrogen induces lung metastasis through a host compartment-specific response. , 2006, Cancer research.

[150]  M. Knowles,et al.  Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer. , 2010, The American journal of pathology.

[151]  M. Knowles,et al.  A Decade of FGF Receptor Research in Bladder Cancer: Past, Present, and Future Challenges , 2012, Advances in urology.

[152]  Mark B. Carter,et al.  The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers , 2011, Nature materials.

[153]  P. Polakis The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.

[154]  M. Katoh WNT signaling in stem cell biology and regenerative medicine. , 2008, Current drug targets.

[155]  R. Manavalan,et al.  Poly(D,L-lactic-co-glycolic acid) nanoencapsulation reduces Erlotinib-induced subacute toxicity in rat. , 2009, Journal of biomedical nanotechnology.

[156]  Dean Y. Li,et al.  Blocking Fibroblast Growth Factor Receptor Signaling Inhibits Tumor Growth, Lymphangiogenesis, and Metastasis , 2012, PloS one.

[157]  P. Kuo,et al.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. , 2012, International journal of biochemistry and molecular biology.

[158]  Yan Liu,et al.  Cell and molecular mechanisms of insulin-induced angiogenesis , 2008, Journal of cellular and molecular medicine.

[159]  Chiang-Ching Huang,et al.  Identification of estrogen-responsive genes involved in breast cancer metastases to the bone , 2007, Clinical & Experimental Metastasis.

[160]  Zdenka Kuncic,et al.  Nanoparticles in cancer imaging and therapy , 2012 .

[161]  P. Brown,et al.  Transcriptional Program Induced by Wnt Protein in Human Fibroblasts Suggests Mechanisms for Cell Cooperativity in Defining Tissue Microenvironments , 2007, PloS one.

[162]  G. Dontu,et al.  Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.

[163]  Ji-Xin Shi,et al.  Growth Factors from Tumor Microenvironment Possibly Promote the Proliferation of Glioblastoma-Derived Stem-like Cells in Vitro , 2012, Pathology & Oncology Research.

[164]  M. von Knebel Doeberitz,et al.  Wnt/β‐catenin‐pathway as a molecular target for future anti‐cancer therapeutics , 2005 .

[165]  Z. Duan,et al.  Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells. , 2011, Molecular pharmaceutics.

[166]  John Kuriyan,et al.  Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 , 2009, Proceedings of the National Academy of Sciences.

[167]  A. Naderi,et al.  A feedback loop between androgen receptor and ERK signaling in estrogen receptor-negative breast cancer. , 2011, Neoplasia.

[168]  K. Makino,et al.  HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. , 2000, Cancer research.

[169]  K. Alitalo,et al.  Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[170]  P. Lollini,et al.  Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling , 2011, Oncogene.

[171]  Wing-Kai Chan,et al.  Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer , 2007, Clinical Cancer Research.

[172]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[173]  N. Evans,et al.  The Wnt Signaling Receptor Lrp5 Is Required for Mammary Ductal Stem Cell Activity and Wnt1-induced Tumorigenesis* , 2006, Journal of Biological Chemistry.

[174]  Miqin Zhang,et al.  pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. , 2010, Molecular pharmaceutics.

[175]  F. Peruzzi,et al.  MINI REVIEW THE IGF-1 RECEPTOR IN CANCER BIOLOGY , 2003 .

[176]  M. Giacca,et al.  Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease , 2010, Cell.

[177]  T. Golde,et al.  Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy , 2012, Vascular cell.

[178]  F. Radtke,et al.  Notch and cancer: a double-edged sword , 2007, Cellular and Molecular Life Sciences.

[179]  Michael Kahn,et al.  Targeting Wnt Signaling: Can We Safely Eradicate Cancer Stem Cells? , 2010, Clinical Cancer Research.

[180]  R. Loberg,et al.  Enhanced Glycogen Synthase Kinase-3β Activity Mediates Hypoxia-induced Apoptosis of Vascular Smooth Muscle Cells and Is Prevented by Glucose Transport and Metabolism* , 2002, The Journal of Biological Chemistry.

[181]  M. Katoh,et al.  WNT Signaling Pathway and Stem Cell Signaling Network , 2007, Clinical Cancer Research.

[182]  Yutaka Shimada,et al.  Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours , 2003, Nature.

[183]  J. Hancock PA promoted to manager , 2007, Nature Cell Biology.

[184]  R. Clarke,et al.  Breast cancer stem cells: something out of notching? , 2010, Cancer research.

[185]  S. Izraeli,et al.  Molecular Pathways Regulating Pro-migratory Effects of Hedgehog Signaling* , 2006, Journal of Biological Chemistry.

[186]  Yingqun Wang,et al.  Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy , 2009, Molecular Cancer Therapeutics.

[187]  Ravi S Kane,et al.  Regulation of stem cell signaling by nanoparticle-mediated intracellular protein delivery. , 2011, Biomaterials.

[188]  M. Rubini,et al.  Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[189]  E. Kremmer,et al.  Neoplastic transformation by Notch is independent of transcriptional activation by RBP-J signalling , 2000, Oncogene.

[190]  V. Speirs,et al.  Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model , 2003, The Journal of pathology.

[191]  J. Otlewski,et al.  FGF1-gold nanoparticle conjugates targeting FGFR efficiently decrease cell viability upon NIR irradiation , 2012, International journal of nanomedicine.

[192]  C. Kahn,et al.  Characterization of Multiple Signaling Pathways of Insulin in the Regulation of Vascular Endothelial Growth Factor Expression in Vascular Cells and Angiogenesis* , 2003, Journal of Biological Chemistry.

[193]  Yihai Cao,et al.  Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. , 2002, Cancer Cell.

[194]  E. Wilander,et al.  Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. , 1993, Cancer research.

[195]  P. Hwu Gene therapy: progress and prospects. , 1994, Contemporary urology.

[196]  J. McCubrey,et al.  Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R Mediated Cell Cycle Progression and Prevention of Apoptosis in Hematopoietic Cells , 2004, Cell cycle.

[197]  J. Yoon,et al.  Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis. , 2010, Cancer research.

[198]  H. Stein,et al.  Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. , 2004, Blood.

[199]  Arie Perry,et al.  Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth , 2004, Cancer Research.

[200]  Xiaohua Huang,et al.  Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. , 2006, Journal of the American Chemical Society.

[201]  Christian Fischer,et al.  FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? , 2008, Nature Reviews Cancer.

[202]  F. Frasca,et al.  The role of insulin receptors and IGF-I receptors in cancer and other diseases , 2008, Archives of physiology and biochemistry.

[203]  J. McCubrey,et al.  The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients , 2010, Oncotarget.

[204]  Luigi Marchionni,et al.  The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance , 2010, Clinical Cancer Research.

[205]  Y. Kuo,et al.  Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. , 2011, Biomaterials.

[206]  X. Shuai,et al.  Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. , 2010, European journal of radiology.

[207]  W. Ruf,et al.  Tissue factor proangiogenic signaling in cancer progression. , 2012, Thrombosis research.

[208]  S. Weiss,et al.  A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. , 2006, Nature cell biology.

[209]  Zhiwei Wang,et al.  Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of notch-1 and nuclear factor-κB signaling , 2007 .

[210]  R L Vessella,et al.  Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1 , 2001 .

[211]  M. Scott,et al.  Patched 1 Regulates Hedgehog Signaling at the Primary Cilium , 2022 .

[212]  L. Nicholson,et al.  Ras‐MEK‐ERK signaling cascade regulates androgen receptor element‐inducible gene transcription and DNA synthesis in prostate cancer cells , 2007, International journal of cancer.

[213]  Cun-Yu Wang,et al.  Notch signaling in the regulation of tumor angiogenesis. , 2006, Trends in cell biology.

[214]  L. Aiello,et al.  Vascular Endothelial Growth Factor Induces Expression of Connective Tissue Growth Factor via KDR, Flt1, and Phosphatidylinositol 3-Kinase-Akt-dependent Pathways in Retinal Vascular Cells* , 2000, The Journal of Biological Chemistry.

[215]  T. Giordano,et al.  Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.

[216]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[217]  Xiaohua Huang,et al.  Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. , 2006, Cancer letters.

[218]  C. Iacobuzio-Donahue,et al.  Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.

[219]  J. Allalunis-Turner,et al.  Notch signaling as a therapeutic target for breast cancer treatment? , 2011, Breast Cancer Research.

[220]  Yihai Cao Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands , 2009, Science Signaling.

[221]  J. Aster,et al.  Notch Signaling in Cancer , 2002, Cancer biology & therapy.

[222]  J. Hartman,et al.  Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .

[223]  P. Medina,et al.  Mammalian target of rapamycin: biological function and target for novel anticancer agents. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[224]  Ana M Soto,et al.  The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.

[225]  T. Ohtsuka,et al.  Oscillations in notch signaling regulate maintenance of neural progenitors , 2008, International Journal of Developmental Neuroscience.

[226]  P. Pantazis,et al.  Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism , 2011, Journal of nanobiotechnology.

[227]  D. Feldman,et al.  The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.

[228]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[229]  W. Hennink,et al.  Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[230]  A. Ostman PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. , 2004, Cytokine & growth factor reviews.

[231]  T. Beißbarth,et al.  β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis. , 2011, Carcinogenesis.

[232]  H. Werner,et al.  Differential Regulation of Insulin-like Growth Factor-I (IGF-I) Receptor Gene Expression by IGF-I and Basic Fibroblastic Growth Factor* , 1997, The Journal of Biological Chemistry.

[233]  P. Friedl,et al.  Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.

[234]  M. Bidet,et al.  The Hedgehog Receptor Patched Functions in Multidrug Transport and Chemotherapy Resistance , 2012, Molecular Cancer Research.

[235]  A. Belfiore,et al.  In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A , 2002, Oncogene.

[236]  M. Knowles,et al.  Alternative splicing of fibroblast growth factor receptor 3 produces a secreted isoform that inhibits fibroblast growth factor-induced proliferation and is repressed in urothelial carcinoma cell lines. , 2005, Cancer research.

[237]  Raoul Kopelman,et al.  Multifunctional nanoparticle platforms for in vivo MRI enhancement and photodynamic therapy of a rat brain cancer , 2005 .

[238]  Xiang Du,et al.  Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. , 2008, World journal of gastroenterology.

[239]  M. Tenhagen,et al.  Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets. , 2012, Endocrine-related cancer.

[240]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[241]  Y. Omidi,et al.  c-Src antisense complexed with PAMAM denderimes decreases of c-Src expression and EGFR-dependent downstream genes in the human HT-29 colon cancer cell line. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[242]  A. Hong,et al.  The effects of luminescent ruthenium(II) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling. , 2013, Biomaterials.

[243]  S. R. Datta,et al.  Cellular survival: a play in three Akts. , 1999, Genes & development.

[244]  M. Landthaler,et al.  High frequency of FGFR3 mutations in adenoid seborrheic keratoses. , 2006, The Journal of investigative dermatology.

[245]  FlorenceSchaffner,et al.  Tissue Factor and PAR2 Signaling in the Tumor Microenvironment , 2009 .

[246]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[247]  Melissa H Wong,et al.  Tumor microenvironment complexity: emerging roles in cancer therapy. , 2012, Cancer research.

[248]  J. Ambati,et al.  Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth , 2009 .

[249]  M. Washington,et al.  Mice expressing activated PI3K rapidly develop advanced colon cancer. , 2012, Cancer research.

[250]  M. Wolter,et al.  Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1998, Cancer research.

[251]  Robert Geisler,et al.  Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation , 2000, Nature.

[252]  J. Frystyk Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis. , 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[253]  Carlos S. Moreno,et al.  MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.

[254]  D. A. Foster Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. , 2009, Biochimica et biophysica acta.

[255]  P. Kabos,et al.  Blocking HES1 Expression Initiates GABAergic Differentiation and Induces the Expression of p21CIP1/WAF1 in Human Neural Stem Cells* , 2002, The Journal of Biological Chemistry.

[256]  Shiladitya Sengupta,et al.  Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis , 2009, Angiogenesis.

[257]  Dieter Niederacher,et al.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene , 2010, Nature Genetics.

[258]  D. Leroith,et al.  The role of the IGF system in cancer growth and metastasis: overview and recent insights. , 2007, Endocrine reviews.

[259]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[260]  M. Knowles,et al.  Fibroblast growth factor receptor 1 promotes proliferation and survival via activation of the mitogen-activated protein kinase pathway in bladder cancer. , 2009, Cancer research.

[261]  Enrique Casado,et al.  PI3K/Akt signalling pathway and cancer. , 2004, Cancer treatment reviews.

[262]  S. Hanks,et al.  Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. , 2009, Cancer research.

[263]  M. Bittner,et al.  The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition* , 2007, Journal of Biological Chemistry.

[264]  G. Bu,et al.  LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy , 2010, Proceedings of the National Academy of Sciences.

[265]  R. Samant,et al.  Hedgehog Signaling: Networking to Nurture a Promalignant Tumor Microenvironment , 2011, Molecular Cancer Research.

[266]  S. Baker,et al.  PTEN and the PI3-kinase pathway in cancer. , 2009, Annual review of pathology.

[267]  G. Bepler,et al.  Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor Survival In vivo in Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[268]  C. Heldin,et al.  Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. , 1992, Cancer research.

[269]  Sailing He,et al.  Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging. , 2012, Biomaterials.

[270]  P. V. Van Veldhuizen,et al.  Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1 , 2010, Molecular Cancer.

[271]  D. Hwang,et al.  Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer. , 2012, The Journal of clinical investigation.

[272]  B. Gallez,et al.  Nitric oxide delivery to cancer: why and how? , 2009, European journal of cancer.

[273]  N. Kennedy,et al.  Role of JNK in Tumor Development , 2003, Cell cycle.

[274]  A. Costantino,et al.  Insulin Receptor Isoform A, a Newly Recognized, High-Affinity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells , 1999, Molecular and Cellular Biology.

[275]  M. Kuwano,et al.  Molecular Mechanisms of Epidermal Growth Factor Receptor (EGFR) Activation and Response to Gefitinib and Other EGFR-Targeting Drugs , 2006, Clinical Cancer Research.

[276]  A. Belfiore The role of insulin receptor isoforms and hybrid insulin/IGF-I receptors in human cancer. , 2007, Current pharmaceutical design.

[277]  S. Vyas,et al.  Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. , 2011, Journal of biomedical nanotechnology.

[278]  A. Sood,et al.  Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer , 2011, Clinical Cancer Research.

[279]  R. Baserga,et al.  Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes , 1995, Journal of virology.

[280]  R. Cardiff,et al.  Deregulation of Stat5 expression and activation causes mammary tumors in transgenic mice , 2004, International journal of cancer.

[281]  H. Klocker,et al.  Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor. , 1994, Cancer research.

[282]  R. Radhakrishnan,et al.  ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation , 2010, Proceedings of the National Academy of Sciences.

[283]  J. Pessin,et al.  Relationship between alpha subunit ligand occupancy and beta subunit autophosphorylation in insulin/insulin-like growth factor-1 hybrid receptors. , 1993, The Journal of biological chemistry.

[284]  Qiong Chen,et al.  Magnetic iron oxide nanoparticles carrying PTEN gene to reverse cisplatin-resistance of A549/CDDP cell lines , 2012 .

[285]  D. Luo,et al.  Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.

[286]  Dong Liang,et al.  Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts. , 2011, Biomaterials.

[287]  Noah Craft,et al.  A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.

[288]  Bo Mu,et al.  The pigment epithelial-derived factor gene loaded in PLGA nanoparticles for therapy of colon carcinoma. , 2010, Oncology reports.

[289]  J. M. Marchetti,et al.  Photobiological and Ultrastructural Studies of Nanoparticles of Poly(lactic-co-glycolic acid)-Containing Bacteriochlorophyll-a as a Photosensitizer Useful for PDT Treatment , 2005, Drug delivery.

[290]  M. Hiraoka,et al.  The Akt/mTOR Pathway Assures the Synthesis of HIF-1α Protein in a Glucose- and Reoxygenation-dependent Manner in Irradiated Tumors* , 2009, Journal of Biological Chemistry.

[291]  J. Shih,et al.  Xwnt-5A: a maternal Wnt that affects morphogenetic movements after overexpression in embryos of Xenopus laevis. , 1993, Development.

[292]  Tian-Li Wang,et al.  Jagged1 Expression Regulated by Notch3 and Wnt/β-catenin Signaling Pathways in Ovarian Cancer , 2010, Oncotarget.

[293]  D. Olson,et al.  Antisense wnt-5a mimics wnt-1-mediated C57MG mammary epithelial cell transformation. , 1998, Experimental cell research.

[294]  José M. Morachis,et al.  Triggered Rapid Degradation of Nanoparticles for Gene Delivery , 2012, Journal of drug delivery.

[295]  François Guillemin,et al.  Nanoparticles as vehicles for delivery of photodynamic therapy agents. , 2008, Trends in biotechnology.

[296]  Jong-Suk Kim,et al.  Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway , 2008, European Respiratory Journal.

[297]  C. Stewart,et al.  Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. , 1996, Physiological reviews.

[298]  M. Knowles,et al.  FGFR1-Induced Epithelial to Mesenchymal Transition through MAPK/PLCγ/COX-2-Mediated Mechanisms , 2012, PloS one.

[299]  F. Uckun,et al.  Therapeutic nanoparticle constructs of a JAK3 tyrosine kinase inhibitor against human B-lineage ALL cells , 2010, Arzneimittelforschung.

[300]  H. Masoudi,et al.  Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival. , 2008, Cancer research.

[301]  Randall T Moon,et al.  Wnt and calcium signaling: beta-catenin-independent pathways. , 2005, Cell calcium.

[302]  Yutaka Matsuda,et al.  Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation , 2007, Breast Cancer Research.

[303]  H. Scher,et al.  Collocation of androgen receptor gene mutations in prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[304]  J. Iwasaki,et al.  Anti-angiogenic therapy against gastrointestinal tract cancers. , 2009, Japanese journal of clinical oncology.

[305]  D. McDonnell,et al.  Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. , 2005, Molecular interventions.

[306]  Fahima Dilnawaz,et al.  Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. , 2009, Biomaterials.

[307]  M. E. Kenney,et al.  Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery? , 2011, Small.

[308]  T. Golde,et al.  Rational targeting of Notch signaling in cancer , 2008, Oncogene.

[309]  M. Guarino Src signaling in cancer invasion , 2010, Journal of cellular physiology.

[310]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[311]  R. Gurny,et al.  Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. , 2006, International journal of pharmaceutics.

[312]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[313]  D. Santini,et al.  p66Shc/Notch‐3 Interplay Controls Self‐Renewal and Hypoxia Survival in Human Stem/Progenitor Cells of the Mammary Gland Expanded In Vitro as Mammospheres , 2007, Stem cells.

[314]  R. Mumper,et al.  In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[315]  Lin Mei,et al.  Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. , 2013, Biomaterials.

[316]  N. López-Bigas,et al.  Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer , 2009, Proceedings of the National Academy of Sciences.

[317]  S. Chandarlapaty,et al.  PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer , 2011, Oncogene.

[318]  C. Nguyen,et al.  Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes , 1999, Oncogene.

[319]  A. Ciucci,et al.  Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor. , 2006, The American journal of pathology.

[320]  Yiling Lu,et al.  Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades* , 2003, Journal of Biological Chemistry.

[321]  T. Golde,et al.  Targeting Notch to Target Cancer Stem Cells , 2010, Clinical Cancer Research.

[322]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[323]  Tara Karnezis,et al.  VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. , 2012, Cancer cell.

[324]  S. Fuqua,et al.  Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. , 2011, Cancer research.

[325]  M. Stampfer,et al.  Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. , 2008, The Lancet. Oncology.

[326]  R. Nicholson,et al.  Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells , 2006, British Journal of Cancer.

[327]  J. Hartman,et al.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[328]  S. Aaronson,et al.  An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.

[329]  A. Cuschieri,et al.  Hybrid gold-iron oxide nanoparticles as a multifunctional platform for biomedical application , 2012, Journal of Nanobiotechnology.

[330]  S. Wise Nanocarriers as an emerging platform for cancer therapy , 2007 .

[331]  Ira Pastan,et al.  Immunotoxin therapy of cancer. , 1993, Nature reviews. Cancer.